{"id":"NCT00644787","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain","officialTitle":"A Phase II/III Study of JNS020QD in Cancer Pain Patients - A Dose-Finding, Double-Blind Study of JNS020QD Compared With JNS005 in Patients Previously Untreated With Opioid Analgesics","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-12","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2008-03-27","resultsPosted":"2013-05-21","lastUpdate":"2013-06-13"},"enrollment":156,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Cancer"],"interventions":[{"type":"DRUG","name":"Fentanyl 1-day transdermal patch (Titration Phase)","otherNames":["JNS020QD"]},{"type":"DRUG","name":"Fentanyl 1-day transdermal patch (Double Blind Phase)","otherNames":["JNS020QD"]},{"type":"DRUG","name":"Fentanyl 3-day transdermal patch (Double Blind Phase)","otherNames":["JNS005"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Fentanyl 1-day transdermal patch (Titration Phase)","type":"EXPERIMENTAL"},{"label":"Fentanyl 1-day transdermal patch (Double Blind Phase)","type":"EXPERIMENTAL"},{"label":"Fentanyl 3-day transdermal patch (Double Blind Phase)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of fentanyl 1-day application (JNS020QD) transdermal patch (patch containing a drug that is put on the skin so the drug can enter the body through the skin) and to assess the non-inferiority of fentanyl 1-day application transdermal patch to fentanyl 3-day application (JNS005) transdermal patch in participants with cancer pain.","primaryOutcome":{"measure":"Percentage of Participants Achieving Dose Titration Success","timeFrame":"Day 14 or early discontinuation (ED)","effectByArm":[{"arm":"Fentanyl 1-day Transdermal Patch (Titration Phase)","deltaMin":80.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":43,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":155},"commonTop":["Somnolence","Constipation","Nausea","Vomiting","Diarrhoea"]}}